Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Wed, Apr 30, 2025 07:21 AM All times are UTC

Follow Series

©Econometrics LLC 2025. All Rights Reserved.

Sharon Lewin

Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
Sharon Lewin is an infectious diseases physician and basic scientist. She is the inaugural Director of the Peter Doherty Institute for Infection and Immunity, Professor of Medicine, The University of Melboburne, a consultant infectious diseases physician, Alfred Hospital and an Australian National Health and Medical Research Council (NHMRC) practitioner fellow. She completed her medical training at Monash University, Melbourne; her specialist infectious diseases specialist training at the Royal Melbourne Hospital, Melbourne; her PhD in virology from the Burnet Institute, Melbourne and her post-doctoral fellowship at the Rockefeller University, New York.

Her laboratory focuses on understanding how HIV persists in patients on antiviral therapy and developing strategies to cure HIV infection and the pathogenesis of HIV-HBV co-infection.She is the chief investigator of a National Health and Medical Research Council of Australia (NHMRC) Centre for Research Excellence called the Australian Partnership for Preparedness in Infectious Disease Emergencies (APPRISE), a national network focused on research on pandemic preparedness. She is a member of the Governing Council of the International AIDS Society (IAS) representing the Asia Pacific Region and a member of the council of the NHMRC and chairs the Health Translation Advisory Committee..

She was Melburnian of the Year in 2014 and was awarded the Peter Mills Medal from Research Australia in 2015. In 2019 she was made an Officer of the Order of Australia and a Clarivate high citation researcher.

5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one

Mar 11, 2025 14:57 pm UTC| Insights & Views Health

On March 11, 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially declared a pandemic. More than 7 million people have since died from COVID. The virus, and the public...

Economy

Gold Slips on Eased Tariff Fears, Eyes Key U.S. Economic Data

Gold prices extended their decline during Asian trading on Wednesday as easing U.S. auto tariffs and positive trade signals reduced safe-haven demand. President Donald Trump signed two orders offering tax credits and...

Asian Stocks Mixed as China, Japan Factory Data Disappoint; India, Korea Decline on Geopolitical Risks

Asian stock markets were mostly flat on Wednesday as investors weighed weak factory activity data from China and Japan, alongside Australian inflation figures and heightened regional tensions. Chinas official manufacturing...

Dollar Slumps as Tariff Uncertainty Lifts Euro, Yen, and Swiss Franc

The U.S. dollar held steady on Wednesday but is set for its worst monthly decline since November 2022, falling sharply amid rising global uncertainty over President Donald Trumps volatile trade policies. Retreats from...

Oil Prices Dip Amid Tariff Concerns, Rising Inventories, and OPEC+ Output Worries

Oil prices slipped in early Asian trading Wednesday, pressured by renewed concerns over global economic growth and fuel demand due to U.S. tariff policies and rising crude inventories. Brent crude futures fell 17 cents, or...

U.S. Stock Futures Dip as Investors Monitor Trade Developments, Earnings, and Key Data

U.S. stock futures slipped Tuesday evening as investors digested signs of easing trade tensions, soft economic data, and awaited major corporate earnings. SP 500 futures fell 0.2% to 5,571.75, while Nasdaq 100 futures...

Politics

Carney's Liberals Win Canadian Election Amid Trump Tariff Backlash

Canadian Prime Minister Mark Carneys Liberal Party staged a political comeback, winning 169 electoral districts in Mondays parliamentary election, just shy of a majority. The result, driven by public backlash to U.S....

Trump Touts Economic Record, Promises Tax Cuts at Michigan Rally Amid Recession Fears

President Donald Trump rallied supporters in Warren, Michigan, marking his first 100 days in office with bold claims about the U.S. economy, promises of sweeping tax cuts, and sharp criticism of Democrats. Speaking near...

Tensions Escalate as China, U.S., and Philippines Conduct Rival Patrols in South China Sea

Chinas navy conducted a patrol in the South China Sea on Tuesday, accusing the Philippines of provocations as Filipino and U.S. forces carried out joint aerial patrols over the disputed waters. The move comes amid rising...

U.S. Defense Secretary Scraps Women, Peace and Security Program Citing Military Focus

U.S. Defense Secretary Pete Hegseth announced Tuesday the cancellation of the Women, Peace, and Security (WPS) program, originally enacted by President Donald Trump in 2017 to promote womens participation in global peace...

U.S. Urges India and Pakistan to Avoid Escalation After Kashmir Attack

U.S. Secretary of State Marco Rubio is set to hold talks with his Indian and Pakistani counterparts in an effort to prevent further escalation following a deadly militant attack in India-administered Kashmir. The State...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

Xiaomi Unveils MiMo AI Model, Shares Surge 5% on Breakthrough Launch

Xiaomi Corp (HK:1810) launched its first open-source large language model, MiMo, on Wednesday, marking its official entry into the competitive artificial intelligence space. The debut sent Xiaomis Hong Kong-listed shares...

OpenAI Rolls Back GPT-4o Update After User Backlash Over "Sycophantic" Behavior

OpenAI has rolled back a recent update to its GPT-4o model used in ChatGPT, following widespread criticism from users who found the AI assistant excessively flattering and overly agreeable. The company announced Tuesday...

TSMC Expands U.S. Chip Production With Third Arizona Fab and $100B Investment Boost

Taiwan Semiconductor Manufacturing Co. (NYSE:TSM), the worlds largest contract chipmaker, has officially broken ground on its third semiconductor fabrication plant in Phoenix, Arizona. This marks a major milestone in the...

Meta Launches Standalone AI App to Compete with OpenAI and Google

Meta Platforms (NASDAQ:META) has released a standalone app for its Meta AI assistant, marking a significant step to boost its presence in the rapidly evolving AI market. Previously accessible only through Metas main...

Amazon Enters Satellite Internet Race with First Kuiper Deployment

Amazon (NASDAQ:AMZN) has officially entered the satellite broadband market with the successful launch of 27 operational satellites for Project Kuiper, its high-speed internet initiative aimed at rivaling SpaceXs Starlink....